课题基金 / 基金详情

The Canadian STRIDER Trial: sildenafil for dismal prognosis IUGR.

The Canadian STRIDER Trial: sildenafil for dismal prognosis IUGR.
加拿大 STRIDER 试验：西地那非治疗 IUGR 预后不良。
批准号：
303858
负责人：
Von Dadelszen Peter
金额：
$45.91万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-03-01 至 2019-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=303858&lang=en
关键词：
Fetal Growth Intact Perinatal Survival Intrauterine Growth Restriction Placental Growth Factor Randomised Controlled Trial Sildenafil Citrate

项目摘要

项目成果

Von Dadelszen Peter的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In some pregnancies, the placenta (afterbirth) forms so poorly that the fetus cannot grow adequately and must be delivered too early to survive. We have preliminary data that suggest that using sildenafil citrate (the active drug in Viagra) may improve bl
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The fullPIERS risk prediction model for women with pre-eclampsia: external validation and added value of a novel biomarker
Community Level Interventions for Pre-eclampsia & Geographic Information systems (GIS)
  • 批准号：
    264369
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $1.82万
  • 财政年份：
    2012
  • 负责人：
    Von Dadelszen Peter
  • 依托单位：
    University of British Columbia
Nomination to the 2012 Knowledge Translation Prize
  • 批准号：
    257155
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.29万
  • 财政年份：
    2012
  • 负责人：
    Von Dadelszen Peter
  • 依托单位：
    University of British Columbia
Angiogenic factors in identifying placental intrauterine growth restriction.